Signal Transduction and Targeted Therapy | Bimetallic Nanobomb Activates STING Pathway to Enhance Bispecific T-Cell Engager for Photo-Immunotherapy of Colorectal Cancer

This study develops a novel bimetallic nanobomb, MnO2/Co-DA@BiTE/HPT, which significantly enhances anti-tumor immune responses by synergistically activating the STING pathway, enabling photothermal therapy, and delivering bispecific T-cell engagers, thereby effectively inhibiting colorectal cancer growth and preventing recurrence and metastasis.

 

Literature Overview

The article titled 'Unleashing the potential of bimetallic nanobomb-mediated STING pathway to enhance bispecific T-cell engager against colorectal cancer photo-immunotherapy,' published in the journal Signal Transduction and Targeted Therapy, reviews and summarizes the development of a bimetal-enriched nanobomb, MnO2/Co-DA@BiTE/HPT, for efficient photo-immunotherapy of colorectal cancer. This system integrates STING pathway activation, bispecific T-cell engager (BiTE), and photothermal therapy (PTT), demonstrating significant anti-tumor efficacy in multiple tumor models and inducing long-term immune memory. The study systematically evaluates its pharmacokinetics, biodistribution, immune activation mechanisms, and safety, confirming its potential in improving immunosuppressive microenvironments, enhancing T-cell infiltration, and suppressing tumor growth. This strategy provides new insights into overcoming the limitations of BiTEs in solid tumors and holds significant translational medical value.

Background Knowledge

Colorectal cancer (CRC) is one of the most prevalent and deadly malignancies worldwide. Although immunotherapy has achieved breakthroughs in hematologic tumors, its efficacy in solid tumors remains limited. Bispecific T-cell engagers (BiTEs) are antibodies capable of simultaneously binding CD3 on T cells and tumor-associated antigens (TAAs), recruiting T cells to tumor sites to induce targeted killing. However, BiTE applications in solid tumors face challenges such as short half-life, off-target toxicity, immune tolerance, and 'cold' tumor microenvironments (lacking T-cell infiltration). Therefore, effectively activating anti-tumor immunity and improving the tumor immune microenvironment have become research hotspots.

The STING (stimulator of interferon genes) pathway is a key sensor in innate immunity, activated by cytosolic DNA to induce type I interferon (IFN-I) release, promote antigen-presenting cell (APC) maturation, and thereby activate adaptive immunity. Mn2+ acts as an agonist of cGAS, enhancing STING pathway activation and improving immune surveillance. Photothermal therapy (PTT) induces tumor cell apoptosis via localized heat, releasing tumor-associated antigens and damage-associated molecular patterns (DAMPs), promoting immunogenic cell death (ICD).

Combining BiTEs with STING activators and PTT offers a promising approach to convert 'cold' tumors into 'hot' ones, enhancing T-cell infiltration and function. However, achieving synergistic delivery, targeting, and controllable release of multimodal therapies remains a major challenge. This study constructs a metal–polyphenol coordination-based nanoplatform that efficiently integrates BiTE, STING activation, and PTT, providing an innovative strategy for colorectal cancer immunotherapy.

 

 

Research Methods and Experiments

The study first screened various metal ions for their ability to activate the STING pathway, identifying Mn2+ and Co2+ as strong inducers of IFN-β secretion and STING pathway protein phosphorylation. Subsequently, MnO2/Co-DA nanoparticles were constructed, and BiTE was successfully loaded via coordination between Co2+ and the His-tag of the BiTE. Further functionalization with the HA-PD-L1 aptamer (HPT) through self-assembly enhanced tumor targeting, resulting in the final nanobomb structure, MnO2/Co-DA@BiTE/HPT.

The morphology, structure, and composition of the nanoparticles were characterized using TEM, CD spectroscopy, XPS, and ICP-MS. Their photothermal performance, ROS generation, tumor cell killing efficacy, and immune activation were evaluated in vitro. A co-culture system using CT26 colorectal cancer cells and bone marrow-derived dendritic cells (BMDCs) was established to assess DC maturation, T-cell activation, and cytokine secretion.

In a CT26 mouse colorectal cancer model, nanoparticles were administered via tail vein injection to evaluate in vivo pharmacokinetics and biodistribution. Anti-tumor efficacy was assessed in subcutaneous, distant, lung metastasis, and postoperative recurrence models. Tumor-infiltrating immune cell subsets were analyzed by flow cytometry, while qPCR and Western blot were used to detect gene and protein expression related to the STING pathway. RNA-seq was performed to analyze transcriptomic changes in tumor tissues, revealing the therapeutic mechanism. Biosafety was also evaluated through body weight changes, H&E staining, blood biochemistry, and long-term toxicity.

Key Conclusions and Perspectives

• The bimetallic Mn2+/Co2+ system synergistically activates the STING pathway, significantly enhancing IFN-β secretion and DC maturation, thereby creating a favorable immune environment for T-cell activation
• The MnO2/Co-DA@BiTE/HPT nanobomb exhibits excellent near-infrared responsiveness with a photothermal conversion efficiency of 30.23%, enabling PTT-mediated localized hyperthermia
• PTT promotes tumor cell DNA damage and ICD, releasing dsDNA and TAAs, which synergize with Mn2+/Co2+ to amplify STING signaling, effectively 'heating up' cold tumor microenvironments
• HPT modification significantly enhances the nanoparticle's targeting to PD-L1-overexpressing colorectal cancer cells, reducing off-target effects and improving drug accumulation
• In multiple colorectal cancer models, the MnO2/Co-DA@BiTE/HPT + laser treatment group significantly suppressed tumor growth, prolonged survival, and effectively inhibited distant tumors and lung metastasis
• This therapeutic strategy substantially increases intratumoral CD8+ T-cell infiltration, promotes DC maturation, reduces Treg cell proportions, and induces robust systemic anti-tumor immune responses
• RNA-seq and GSEA analyses confirm significant upregulation of immune-related pathways such as inflammatory response, TNF, and IFN-γ signaling post-treatment, along with enhanced expression of key STING pathway molecules
• The nanosystem demonstrates excellent biocompatibility with no significant systemic toxicity, indicating strong potential for clinical translation

Research Significance and Prospects

This study presents an innovative multimodal synergistic immunotherapy strategy that integrates STING activation, BiTE-mediated T-cell recruitment, and PTT-induced immunogenic cell death, effectively overcoming the limitations of BiTEs in solid tumor therapy. The nanoplatform enables targeted delivery, responsive release, and multi-mechanistic synergy, significantly enhancing anti-tumor immune responses.

This work provides new insights for colorectal cancer immunotherapy, and its design principles can be extended to other solid tumors. Future studies could further optimize the stability, drug-loading efficiency, and immunomodulatory capacity of the nanocarrier, and explore combinations with other immune checkpoint inhibitors. Additionally, safety and efficacy should be validated in non-human primates to advance clinical translation.

 

 

Conclusion

This study successfully developed a multifunctional photo-immunotherapy platform based on a bimetallic nanobomb, MnO2/Co-DA@BiTE/HPT, to enhance the efficacy of bispecific T-cell engagers in colorectal cancer. The system leverages Mn2+ and Co2+ to synergistically activate the STING pathway, combined with PTT-induced DNA damage, to effectively reverse immunosuppressive microenvironments and promote T-cell infiltration and activation. HPT modification confers excellent tumor targeting, minimizing off-target toxicity. In multiple animal models, this strategy demonstrated potent anti-tumor activity, significantly suppressing primary, distant, and metastatic tumor growth while inducing long-term immune memory to prevent recurrence. Mechanistic studies confirmed activation of the cGAS-STING pathway, upregulation of inflammatory and IFN-related signaling, and remodeling of the anti-tumor immune microenvironment. The nanosystem exhibits favorable biocompatibility and offers an innovative solution to overcome the clinical bottlenecks of BiTEs in solid tumors, holding broad potential for clinical translation.

 

Min Mu, Hui Li, Bo Chen, Aiping Tong, and Bingwen Zou. Unleashing the potential of bimetallic nanobomb-mediated STING pathway to enhance bispecific T-cell engager against colorectal cancer photo-immunotherapy. Signal Transduction and Targeted Therapy.